- Book
- April 2018
- 248 Pages
- Book
- March 2018
- 308 Pages
- Book
- January 2024
- 864 Pages
- Book
- December 2023
- 864 Pages
- Book
- July 2023
- 320 Pages
- Book
- January 2023
- 304 Pages
- Book
- April 2022
- 656 Pages
Global
- Book
- November 2021
- 512 Pages
- Book
- January 2017
- 504 Pages
- Book
- October 2013
- 304 Pages
- Book
- March 2010
- 720 Pages

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy.
The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more